PP
EDIT icon

Paloma Partners’s Editas Medicine EDIT Stock Holding History

Paloma Partners’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-19,416
Closed -$66.2K – 516
2024
Q3 		$66.2K Buy
+19,416
New +$84.5K ﹤0.01% 1061
2021
Q2 		– Sell
-15,396
Closed -$647K – 1887
2021
Q1 		$647K Buy
+15,396
New +$877K 0.01% 944
2019
Q1 		– Sell
-9,900
Closed -$225K – 1743
2018
Q4 		$225K Buy
+9,900
New +$269K 0.01% 994
2018
Q2 		– Sell
-7,360
Closed -$244K – 1749
2018
Q1 		$244K Buy
+7,360
New +$262K ﹤0.01% 1714
2016
Q3 		– Sell
-10,333
Closed -$252K – 1899
2016
Q2 		$252K Buy
+10,333
New +$349K ﹤0.01% 1847

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Paloma Partners's EDIT Position: Q4 2024 in Review

Paloma Partners sold out of Editas Medicine (EDIT) in Q4 2024, closing a stake of 19,416 shares — an estimated $66.2K sold.

Paloma Partners first reported a position in EDIT in Q2 2016 and held it in 5 quarters. The position peaked at $647K in Q1 2021. 206 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.

  • Paloma Partners reported no remaining Editas Medicine position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 19,416 Editas Medicine shares in Q4 2024, an estimated $66.2K.
  • Paloma Partners first reported a position in Editas Medicine in Q2 2016 and held it in 5 quarters.
  • Paloma Partners's Editas Medicine position peaked at $647K in Q1 2021.
  • 206 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.